Cardiac Autoantibodies to Myosin and Other Heart-specific Autoantigens in Myocarditis and Dilated Cardiomyopathy
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 34 (3) , 199-204
- https://doi.org/10.3109/08916930109007385
Abstract
Dilated cardiomyopathy (DCM) is characterized by dilation and impaired contraction of the left ventricle or both; it is a relevant cause of heart failure and a common indication for heart transplantation. It may be idiopathic, familial/genetic, viral, autoimmune or immune-mediated, associated with a viral infection. Myocarditis is an inflammatory disease of the myocardium; it may be idiopathic, infectious or autoimmune and may heal or lead to DCM. Thus, in a patient subset, myocarditis and DCM are thought to represent the acute and chronic stages of an organ-specific autoimmune disease of the myocardium. In keeping with this hypothesis, autoimmune features in patients with myocarditis/DCM include: familial aggregation, a weak association with HLA-DR4, abnormal expression of HLA class II on cardiac endothelium on endomyocardial biopsy, detection of organ-and disease-specific cardiac autoantibodies in the sera of affected patients and of symptom-free relatives. The organ-specific cardiac autoantibodies detected by immunofluorescence are directed against multiple antigens. One of these, first identified using immunoblotting and confirmed by ELISA, is the cardiac-specific α-myosin isoform. Myosin fulfils the expected criteria for organ-specific autoimmunity, in that immunization with cardiac but not skeletal myosin reproduces, in susceptible mouse strains, the human disease phenotype of myocarditis/DCM; in addition, a-myosin is entirely cardiac-specific. The organ-specific cardiac autoantibodies detected by immunofluorescence in symptom-free relatives were associated with echocardiographic features suggestive of early disease. Short-term follow-up is in keeping with this interpretation, although extended follow-up is necessary to define better the role of the antibody as predictor of disease susceptibility in healthy subjects at risk of myocarditis/DCM, such as first-degree relatives.Keywords
This publication has 29 references indexed in Scilit:
- Defining criteria for autoimmune diseases (Witebsky's postulates revisited)Published by Elsevier ,2003
- AbstractJournal of the American College of Cardiology, 1997
- Recognition and Optimum Management of MyocarditisDrugs, 1996
- Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy.Heart, 1995
- Role of autoimmunity in dilated cardiomyopathyHeart, 1994
- Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blottingJournal of the American College of Cardiology, 1993
- Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.Journal of Clinical Investigation, 1993
- Organ-specific cardiac antibodies: serological markers for systemic hypertension in autoimmune polyendocrinopathyThe Lancet, 1991
- Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.Journal of Clinical Investigation, 1990
- Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathyJournal of the American College of Cardiology, 1990